In this task, you need to Translate Czech text to English.

[EX Q]: Acylaminoalkylidenhydroxybisfosfonov  kyseliny obecn ho vzorce I, v n m  A znamen  skupinu -(CH.sub.2.n.).sub.n.n.-, v n   n znamen  cel    slo 1 a  10 a R-CO znamen  acylov² zbytek zn m  slou eniny s protiz n tliv²m · inkem ze skupiny kyseliny salicylov , aryloctov , arylpropionov , anthranilov , 4,5-dihydroxy- nebo 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenkarboxylov  nebo nikotinov . Zp sob v²roby spo  v  v reakci RCOOH nebo jej ho chloridu s aminoalkylidenhydroxybisfosfonovou kyselinou. Jsou pops ny farmaceutick  prost°edky, obsahuj c  n rokovan  slou eniny a vhodn  k l  en  onemocn n  kost , kloub  a pojivov²ch tk n .\
[EX A]: In the present invention there are disclosed acylamino-alkylidene-hydroxy-bisphosphonic acids of the general formula I, in which A represents the -(CHi2)in-, in which n represents an integer ranging from 1 to 10 and R-CO represents an acyl radical of a known compound exhibiting antiphlogistic activity being selected from a group comprising salicylic acid, aryl acetic acid, aryl propionic acid, anthranilic acid, 4,5-dihydroxy- or 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene carboxylic or nicotinic acid. The preparation process thereof comprises reacting RCOOH or chloride thereof with amino-alkylidene-hydroxy-bisphosphonic acid. In the present invention there are also described pharmaceutical preparations in which the above claimed compounds are comprised and that are suitable for treating bone, joint and connective tissue diseases.

[EX Q]: Použití antagonistu D3 receptoru dopaminu pro prípravu léciv pro lécbu poruch funkce ledvin. Použití, ve kterém antagonistou receptoru je 5-amino-3-(4-(4-(2-terc.-butyl-6-trifluormethyl)pyrimidin-4-yl)-piperazin-1-yl)-2-methyl-but-2-en-1-yl-merkapto)-4-methyl-1,2,4-(4H)-triazol nebo fumarát 2-(3-(4-(2-terc.-butyl-6-trifluormethyl)pyrimidin-4-yl)piperazin-1-yl)propylmerkaptopyrimidin-4-olu.
[EX A]: The present invention relates to the use of dopamine D3 receptor antagonists for the preparation of medicaments for treating renal function disorders wherein the receptor antagonist is 5-amino-3-(4-(4-(2-t-butyl-6-trifluoromethyl)pyrimidin-4-yl)-piperazin-1-yl)-2-methylbut-2-eny-1-yl-mercapto)-4-methyl-1,2,4-(4H)-triazole or 2-(3-(4-(2-t-butyl-6-trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)propylmercaptopyrimidin-4-ole fumarate.

[EX Q]: Prostredek aktivní balistické ochrany na bázi explozí vytvoreného projektilu, urcený zejména pro pancérovou pásovou, kolovou i stacionární techniku, sestává z lineárního projektilového profilu, explozí vytvoreného z kovové vlozky (1) prostrednictvíminiciacní táhlé náloze (2) z plastické trhaviny. Iniciacní táhlá náloze (2) je upravena na zadní stene kovové vlozky (1).
[EX A]:
The means of active ballistic explosion-based projectile design, designed especially for armor-belt, wheeled and stationary technology, consists of a linear projectile profile, an explosion made of a metal insert (1) through a plasticized explosive drawstring (2). Initial draw bar (2) is provided on the back wall of the metal insert (1).